NCT04804969 - MyoVista wavECG Clinical Validation Study Versus Low e' on Echocardiogram | Biotech Hunter

Enrollment

575

Participants

Timeline

Start Date

May 10, 2021

Primary Completion Date

November 30, 2023

Study Completion Date

November 30, 2023

Conditions

Cardiac Disease

Interventions

DEVICE

MyoVista wavECG Test

The MyoVista wavECG is a standard 12-Lead high-performance, multi-channel resting interpretive electrocardiograph providing both a Glasgow Interpretive Analysis and unique MyoVista wavECG Information.

Trial Locations (5)

10467

Montefiore Medical Center, The Bronx

19141

Einstein Medical Center, Philadelphia

75204

University of Texas Southwestern Medical Center, Dallas

92037

Scripps Memorial Hospital, La Jolla

02215

Beth Israel Deaconess Medical Center, Boston